Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
2261-2280 of 2629
Name Principal Investigator Institution Study Date Approved Project ID
Reconciling Results of PSA Screening Efficacy Using PLCO and ERSPC data: CISNET modeling project Angela Mariotto NCI, DCCPS, DMB PLCO Nov 12, 2009 2009-0182
New statistical approaches for adjusting seasonal variation in vitamin D concentration measurement, with application in the PLCO nested case-control study of serum vitamin D concentration and prostate cancer risk Kai Yu NCI, DCEG, BB PLCO Nov 11, 2009 2009-0006
Trichomonosis and prostate cancer risk in the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial Siobhan Sutcliffe Washington University PLCO Nov 9, 2009 2009-0556
Telemore length and risk of glioma Preetha Rajaraman NCI, DCEG, REB PLCO Nov 9, 2009 2009-0557
Modifiable risk factors for benign prostatic hyperplasia Siobhan Sutcliffe Washington University PLCO Nov 4, 2009 2009-0167
Investigation of Prostate Cancer Risk Factors and Targeted Screening Amanda Black NCI, DCEG, EBP PLCO Nov 4, 2009 2009-0243
Development and Validation of a Prediction Model for Identifying Small Malignant Pulmonary Nodules Gerard Silvestri Medical University of South Carolina NLST Oct 19, 2009 200910-0040
Factors influencing prostate cancer mortality David Crawford Univeristy of Colorado Health Science Center PLCO Oct 1, 2009 2009-0012
Reproductive history and renal cell carcinoma Mark Purdue NCI, DCEG, OEEB PLCO Oct 1, 2009 2009-0172
Estimated Radiation Dose to Participants Receiving Chest X-Rays in the National Lung Screening Trial (NLST) Michael Flynn Henry Ford Health System NLST Sep 28, 2009 200909-0088
Effects of In-Plane Spatial Resolution on Computer-Aided Diagnosis Features of Small Pulmonary Nodules David Gierada Washington University NLST Sep 3, 2009 200909-0010
Prospective assessment of thyroid cancer risk and exposure to persistent polyhalogenated aromatic hydrocarbons Mary Ward NCI, DCEG PLCO Aug 21, 2009 2009-0518
Participant Tracking and Tracing in the PLCO and NLST/LSS Trials Pamela Marcus NCI, DCP, BRG PLCO Aug 13, 2009 2009-0159
Risk factors for hepatocellular carcinoma in the United States Katherine McGlynn NCI, DCEG, HREB PLCO Jul 23, 2009 2009-0154
A prospective investigation of the relationship between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of head and neck cancers (HNC) and malignant melanomas (MM) Amanda Black NCI, DCEG, EBP PLCO Jul 23, 2009 2009-0035
Serum Melatonin and Subsequent Risk of Prostate Cancer Ann Hsing NCI, DCEG, HREB PLCO Jul 17, 2009 2008-0256
Development of a Pancreatic Cancer Risk Prediction Model Martin Tammemagi Brock University / Henry Ford Health System PLCO Jul 15, 2009 2009-0095
Risk of an Abnormal Suspicious False Positive Screening Exam for Ovarian Cancer in the PLCO Cancer Screening Trial. Sarah Nyante NCI, DCEG, HREB PLCO Jul 10, 2009 2009-0059
Diet, underlying diseases, reproductive factors and CLL/SLL Huei-Ting Tsai NCI, DCEG, GEB PLCO Jun 26, 2009 2009-0106
Participant Tracking and Tracing in the PLCO and NLST/LSS Trials Pamela Marcus National Cancer Institute NLST Jun 22, 2009 200906-0040